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ABSTRACT
This paper describes the construction and characterization of a Brazilian strain of bovine herpesvirus type
1.2a (BoHV-1.2a) with a deletion of the glycoprotein E (gE) gene. The deletion was introduced by co-
transfection of a deletion fragment containing the 5´and 3´gE flanking regions and genomic DNA of wild type
BoHV-1 into bovine cells. Isolation of gE deletion mutant was performed by immunoperoxidase staining with
an anti-gE monoclonal antibody. Viral clones were plaque purified and further examined by restriction
endonuclesase digestion and Southern blot hybridization. This gE deletion mutant will be evaluated as a
vaccinal virus, in order to determine its potential use for a differential vaccine.
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INTRODUCTION
Bovine herpesvirus 1 (BoHV-1), a major pathogen of cattle,
is the agent of infectious bovine rhinotracheitis/infectious
pustular vulvovaginitis virus (IBR/IPV) and it is associated to a
number of other clinical syndromes, including pustular
balanopostitis, abortion, infertility and conjunctivitis (3). BoHV-
1 strains can be subdivided into three distinct genotypes, BoHV-
1.1, BoHV-1.2a and BoHV-1.2b (9). Genotypes 1.1 and 1.2a are
usually more virulent and can be associated to abortions, while
strains from genotype 1.2b are usually less virulent and have
not been related to abortions (2,10). Although such genomic
differences do reflect pathogenic and antigenic differences, to
date there is only one recognized antigenic group (16).
The BoHV-1 genome consists of a double stranded DNA
molecule of about 135 kb, composed of a unique long (UL) and
a unique short regions (US), flanked by an internal (IR) and a
terminal (TR) inverted repeat sequences (13). The viral genome
encodes approximately 70 different proteins, of which eleven
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are glycoproteins. One of these glycoproteins, glycoprotein E
(gE), is encoded by a gene located within the US region (11,17,18).
Glycoprotein E is not essential for viral replication, but in vitro
growth analysis of viral mutants show a decreased cell-to-cell
spread and smaller plaque size for gE negative viruses (11,17).
In addition, gE deletion in vivo has been related to a decreased
virulence in calves (1,14,15).
Both spontaneous and artificially induced viral mutations
have successfully been used in animal vaccine production. An
european gE negative (gE-) BoHV-1.1 strain has been used as a
differential vaccine for the control of BoHV-1 infections, allowing
the differentiation between the immune responses of infected
and vaccinated animals (1,14,15). Although BoHV-1 isolates
are genetically stable, small antigenic variations may occur.
Therefore, autochtonous isolates used for animal vaccine
production may be more efficacious as vaccinal strains when
compared to non-autochtonous strains. In this study we
describe the deletion of the gE gene from a Brazilian isolate of
BoHV-1.2a, a candidate strain for a differential vaccine.
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MATERIALS AND METHODS
Virus strain and cells
The BoHV-1.2 strain SV265 (genotype 1.2a), isolated from
an animal with respiratory disease during an outbreak of IBR in
São Borja, Rio Grande do Sul, Brazil. The virus was multiplied in
Madin Darby bovine kidney (MDBK) or in embryonic bovine
trachea (Ebtr) cells. Cell cultures were kept in Eagle’s minimal
essential medium (EMEM) supplemented with 5% to 10% fetal
calf serum, 0.05 % yeast lactalbumin hydrolysate, 2 mM
glutamine and antibiotics (100 iu/ml penicillin, 100 µg/ml
streptomycin and 20 iu/ml mycostatin).
Viral DNA extraction
Sub-confluent cells grown in 900 cm2 roller bottles were
infected with virus at a multiplicity of infection of 0.1 to 1.
Approximately 36 hours after infection, when cytopatic effect
(CPE) was evident in 90-100% of the cells, the supernatant
was removed, clarified at 5000 x g for 20 minutes and
centrifuged at 100000 x g for two hours at 4°C. The viral pellet
was resuspended in TE (Tris 10mM, EDTA 1mM, pH 7.4) and
treated with sodium dodecil sulfate and proteinase K (final
concentrations of 1% and 100 µg/µl, respectively) for one hour
at 37°C. The viral DNA was extracted with equilibrated phenol,
precipitated with ethanol, resuspended in TE pH 7.4 and stored
at 4°C (12).
Polymerase chain reaction (PCR) and clonings
Amplification and cloning of the 5´ and 3´ gE flanking regions
were performed to obtain the gE deletion fragment, according
to the scheme shown in Fig. 1. The primers used for amplification
of the 5´region were P1: 5'-CGACTGCTTCGTTATGCTGC-3’ and
P2: 5'-GCGAGACCCATTTAACAACCC-3’. For the 3´ region,
primers were P3: 5'- TGTGCCGTCTGACGGAAAGC-3' and P4:
5' -AATCCCCTCCTTCCCCTCC-3’. All primers sequences were
obtained from the database (7). The predicted sizes of 5´ and 3´
gE flanking regions were 1100 base pairs (bp) and 900 bp,
respectively, and the conditions for amplification were: 80°C for
30 seconds, 94°C for 1 minute, 60°C for 1 minute and 72°C for 1
minute. This cycling profile was repeated 15 times and followed
by additional 23 cycles as described: 94°C for 1 minute, 60°C for
1 minute and 72°C for 1 minute. A final extension step at 72°C
for 7 minutes was applied.
All amplification reactions were performed using SV265
isolated DNA as template and both amplicons were examined
by restriction enzyme analysis. Data obtained was compared
with expected fragments based on previously reported BoHV-1
sequences (7). Amplicons were separately cloned in plasmid
pCR 2.1 (TA Cloning Kit, Invitrogen), following the
manufacturer’s specifications. One of the clones containing the
5´gE flanking region was digested with restriction enzymes,
isolated from an agarose gel and subsequently ligated in one of
the 3´gE clones in order to produce the recombinant plasmid
containing both gE flanking regions (gE deletion fragment).
Construction and isolation of the gE- recombinant
Co-transfections were performed by the calcium phosphate
method (4). Wild type viral DNA (2 µg) was co-transfected with
2 µg of the gE deletion fragment in presence of carrier DNA (16
µg of salmon sperm DNA) in Ebtr cells.
Forty eight hours after co-transfection, plates were frozen
and thawed to liberate cell-associated virions. Supernatants of
co-transfection reactions were then used to infect 96 well plates
with pre-formed Ebtr monolayers in order to isolate recombinant
viruses. After visualization of cytopathic effect (CPE) on Ebtr
cells, plates were fixed with 4% paraformaldehyde in phosphate
buffered saline (PBS; 8.5g NaCl, 1.55g Na2HPO4, 0.23g NaH2PO4,
pH 7.2 per liter) and the immunoperoxidase monolayer assay
(IPMA) was performed as described (6), using the anti-gE
monoclonal antibody number 75 (5) as the primary antibody.
Wells with unstained viral plaques were recorded, the
supernatants collected and used to infect 96-well plates with
Ebtr monolayers.
IPMA was performed until the complete isolation (that is,
no stained viral plaques) of gE- virus from wild type virus. The
gE- virus was then submitted to three additional cycles of plaque
purification in 6-well plates under semi-solid medium (1% of
agarose in EMEM).
Restriction enzyme analysis of wild type and gE- viral DNA
DNA from wild type and gE- virus was isolated as described
above and restriction enzyme analysis was performed according
to standard methods (12). Viral DNA was digested with HindIII
and EcoRI, the fragments were separated on a 0.5 % agarose
gel and stained with ethidium bromide following standard
procedures (12).
Southern blot
Digested viral DNA was transferred to hybridization transfer
membrane GeneScreen Plus (Biotechnology Systems) according
to standard methods (12). The gE probe was the 2026 bp insert of
plasmid p318 that harbors the complete gE open reading frame
from the AluI site up to the HincII site. This fragment starts 52
nucleotides upstream the gE start codon and ends 130 nucleotides
downstream the gE stop codon. The 2026 bp fragment was labeled
with 32PdATP using a nick translation kit (Boehringer Manheim)
according to the manufacturer’s instructions.
Membrane hybridization was performed with 10 ng of the
probe diluted in hybridization buffer, pH 7.2 (0.5 M sodium
phosphate buffer, 1 mM EDTA, 7% SDS) at 65°C overnight.
After two washing steps, the membrane was exposed to a storage
phosphor screen (Molecular Dynamics) and the fluorogram was
made using the fluorescence scanning system “storm”
(Molecular Dynamics).
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RESULTS
Construction of the gE- fragment
The PCR of the 5´gE flanking regions originated an amplicon
of the expected size (1100 bp). This fragment, denominated 5’gE-,
was cloned in pCR 2.1 and examined by restriction enzyme analysis
for orientation. The amplicon corresponding to the 3´gE flanking
region however, gave rise to a fragment of 750 bp, 150 bp shorter
than the expected size. This fragment was examined by restriction
enzyme analysis and results carefully compared with previous
published nucleotide sequences of other BoHV-1 strains (7). After
ensuring that, despite its shorter size, the fragment corresponded
to the desired region, it was subcloned along with the 5’gE- region.
Two clones in the correct orientation, containing the 5´-3´gE
flanking regions, were selected and digested with restriction
enzyme PstI to isolate the deletion fragment after gel
electrophoresis. The deletion fragment contains, in total, about
1900 bp, corresponding to the 5´ and 3´gE flanking regions,
separated by 80 nucleotides, which correspond to the plasmid
polylinker. This 80 nucleotides fragment harbors two EcoRI sites,
one immediately downstream the 5´gE flanking region and one
immediately upstream the 3´gE region. According to this approach,
the induced deletion starts 135 nucleotides upstream the gE start
codon and ends 20 nucleotides downstream the gE stop codon.
Co-transfection and isolation of deleted virus
Co-transfection with viral DNA and the deletion fragment
was performed in 6 well plates. About seven hundred viral
plaques were obtained after co-transfection of Ebtr cells with
wild type virus and the gE deletion fragment. Selection of gE-
virus was made by IPMA after infection of co-transfection
supernatants in preformed Ebtr monolayers in 96 well plates.
Two wells showing unstained viral plaques were selected and
their supernatants were used to infect new Ebtr monolayers.
After a new IPMA, completely unstained CPE was detected
(data not shown) and the gE negative virus was submitted to
three rounds of plaque purification.
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Figure 1. Schematic representation of the construction of the
gE deletion fragment. A: The complete BoHV-1.2 genome, UL:
unique long region, US: unique short region, hatched boxes
represent internal and terminal repeats; B: gE gene represented
by the dotted box and flanked by the gI and US9 genes; C:
amplified gE 5' and 3' flanking regions; D: gE deletion fragment,
ligated in pCR2.1. P1-4: primers 1-4; PstI: restriction enzyme
used to liberate the deletion fragment.
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Figure 2. Genomic analysis of wild type and gE negative viral
DNA. Panel A shows the restriction endonuclease fragments of
gE negative (lanes 2 and 3) and wild type viral DNA (lanes 4 and
5). Viral DNA was digested with HindIII (lanes 2 and 4) and with
EcoRI (lanes 3 and 5). Lanes 1 and 6 show the Lambda HindIII
DNA size marker. Panel B shows the results of the hybridization
with the gE probe on digested viral DNA shown in panel A.
Specific hybridization is observed with wild type viral DNA (lane
4, HindIII C, F and L fragments and lane 5, EcoRI D fragment).
The map bellow panels A and B shows the US region, flanked by
internal and terminal repeats (hatched boxes), and HindIII and
EcoRI fragments which are surrounding the gE gene (dotted
box). The map shows the two orientations (ori 1 and 2) of the US
region found with respect to the UL region. The black box
represents the probe used in Southern blot analysis. The PstI
restriction enzyme sites, used to obtain the probe, are indicated.
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Restriction endonuclease analysis
The results of the restriction endonuclease analysis are
shown in Fig. 2, panel A. Digestion with HindIII showed the
disappearance of the 7.2 kilobase (kb) fragment (HindIII L band)
from the deleted viral DNA (panel A, lane 2). Due to the absence
of the HindIII site in the gE gene, HindIII C and F bands also
disappear in gE- viral DNA, giving rise to two new DNA
fragments of about 22.2 kb (after fusion of HindIII C and L) and
19 kb (after fusion of bands F and L). Digestion of gE negative
viral DNA with EcoRI showed that the 17.6 kb fragment
(denominated EcoRI D fragment) disappears and gives rise to
two additional bands with about 11.6 and 4.2 kb (not visible on
gel) (panel A, lane 3). Such genomic alterations were compatible
with the loss of the expected 1.8 kb fragment corresponding to
the gE gene and the insertion of new EcoRI sites in the deletion
fragment. No other major genomic alterations could be detected
in wild type or deleted viral DNA.
Southern Blot
Digested wild type and gE negative viral DNAs were blotted
and probed with the whole gE open reading frame (Fig. 2, panel B).
Wild type DNA showed specific hybridization with the expected
fragments, which are HindIII C, F and L and EcoRI D bands
(panel B, lanes 4 and 5, respectively). No specific hybridization
was observed in gE negative viral DNA, except for a weak signal
with the new HindIII 22.2 and 19 kb and with the new 4.2 EcoRI
fragment. This weak reaction occurred due to the 130 nucleotides
overlap of the gE probe downstream the gE stop codon.
DISCUSSION
The introduction of gene deletions, either naturally or by
genetic engineering, has been used to provide potential
candidate virus strains for vaccine development. Others have
shown that gE- bovine herpesviruses may be suitable vaccine
viruses in differential vaccines (1,14). Although BoHV isolates
are regarded as stable, small antigenic variations may occur
and it is possible that autochtonous isolates are more
antigenically representative of viruses that are affecting a
specific geografical region. Therefore, we developed an
autochtonous gE- BoHV-1 so that, with the use of an anti-gE
serological test, the immune response to the vaccinal virus can
be differentiated from that induced by wild type virus, and yet
retaining most of the antigenic characteristics common to local
BoHV-1 isolates. Other gE- bovine herpesviruses have been
described (1,11,15,18), however, this is the first report on the
introduction of a whole gE deletion on a BoHV-1.2 strain. An
option was made for a BoHV-1.2a in view of the fact that isolates
of this subtype not only may cause respiratory disease but may
also be involved in reproductive disorders, causing miscarriage
(3,15). Consequently, this vaccinal candidate may induce
protection against both respiratory and reproductive disease.
The induction of the gE deletion was investigated by
restriction endonuclease and Southern blot analysis. The pattern
of bands obtained by digesting the wild type viral DNA with
HindIII and EcoRI was according to the restriction maps of the
BoHV-1.2 K22 strain (8). Digestion of deleted viral DNA showed
a new pattern of bands, with the disappearance of HindIII L
band, which corresponded to the loss of a HindIII site inside
the gE gene. Also due to the loss of this HindIII site, we
observed the production of two new fragments after fusion of
HindIII L with C and L with F bands. Genomic alterations in
EcoRI digested DNA were according to insertion of additional
EcoRI sites in the deletion fragment, giving rise to two new
DNA fragments of about 11.6 and 4.2 kb. These results
confirmed the induced deletion of the gE gene from the viral
genome, as well as the absence of gE expression in infected
cells. No additional genomic changes were found, indicating
that no other major rearrangements were produced as a result
of extra unintended recombination events.
Previous studies were performed to access the in vitro
behavior of gE- BoHV-1.1 mutants (1,11). In order to determine
the in vitro growth behavior of the gE- BoHV-1.2 and to make
comparative analysis between BoHV-1.1 and BoHV-1.2, growth
kinetics and viral plaque size of viruses will be determined. Also,
the in vivo effect of infection with deleted virus will be determined
by animal experimental infection, in order to access its potential
as a vaccine candidate strain.
RESUMO
Construção e caracterização de uma amostra de
BoHV-1.2 isolada no Brasil com uma deleção no gene
da glicoproteína E
Este artigo descreve a construção e caracterização de uma
amostra de um herpesvírus bovino tipo 1.2a (BoHV-1.2a) que
apresenta uma deleção na região genômica que codifica a
glicoproteína E (gE). A deleção gênica foi induzida através da
co-transfecção de um fragmento de deleção, contendo as regiões
5´e 3´flanqueadoras da gE, com o DNA viral intacto de uma
amostra viral isolada de um animal que apresentava doença
respiratória. O isolamento do vírus gE negativo (gE-) foi realizado
com auxílio da técnica de imunoperoxidase em que foi utilizado
como anticorpo primário um anticorpo monoclonal anti-gE. O
vírus gE- foi purificado e o DNA isolado desta amostra foi
examinado através das técnicas de análise por enzimas de
restrição e “Southern blot”. Esta amostra gE- será avaliada como
candidata para compor uma vacina diferencial contra a
rinotraqueíte infecciosa dos bovinos.
Palavras-chave: rinotraqueíte infecciosa/vulvovaginite
infecciosa dos bovinos, BoHV-1, vírus deletado, vacina
diferencial
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